Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Drug Discovery

60. Intramuscular and Systemic Induction of the N-Truncated Dystrophin by Out-Of-Frame Exon 2 Skipping Restores Muscle Function in the Dup2 Mouse, Providing Further Support for a Therapeutic Pathway for 5’ DMD Mutations

Molecular Therapy

English

miR-577 Regulates TGFβ Induced Cancer Progression Through a SDPR-modulated Positive Feedback Loop With ERK/NF-κB in Gastric Cancer

English

Research Highlights

English

Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-Arming Capacity in Oncolytic Adenoviruses

English

Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality

English

112. Assessing Potency in Lentiviral Vectors Pseudotyped With VSV-G, RD114 or FV Envelope Glycoproteins

English

A Novel Endogenous Damage Signal, Colony Stimulating Factor 2 (CSF-2), Activates Multiple Beneficial Functions of Adipose Tissues-Derived Mesenchymal Stem Cells

English

325. Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease

English

462. Automated Manufacturing Process for the Production of Genetically Modified Lymphocytes

English

66. Identification and Characterization of a B Cell Aptamer That Targets Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Myelogenous Leukemia (CML)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Drug Discovery

60. Intramuscular and Systemic Induction of the N-Truncated Dystrophin by Out-Of-Frame Exon 2 Skipping Restores Muscle Function in the Dup2 Mouse, Providing Further Support for a Therapeutic Pathway for 5’ DMD Mutations

miR-577 Regulates TGFβ Induced Cancer Progression Through a SDPR-modulated Positive Feedback Loop With ERK/NF-κB in Gastric Cancer

Research Highlights

Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-Arming Capacity in Oncolytic Adenoviruses

Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality

112. Assessing Potency in Lentiviral Vectors Pseudotyped With VSV-G, RD114 or FV Envelope Glycoproteins

A Novel Endogenous Damage Signal, Colony Stimulating Factor 2 (CSF-2), Activates Multiple Beneficial Functions of Adipose Tissues-Derived Mesenchymal Stem Cells

325. Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease

462. Automated Manufacturing Process for the Production of Genetically Modified Lymphocytes

66. Identification and Characterization of a B Cell Aptamer That Targets Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Myelogenous Leukemia (CML)